Galmed Pharmaceuticals Ltd.
GLMD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$8 | -$7 | -$18 | -$32 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1 | $1 | $1 | $2 |
| Change in WC | -$1 | $0 | -$2 | -$2 |
| Other Non-Cash | $2 | -$0 | $0 | $0 |
| Operating Cash Flow | -$6 | -$6 | -$19 | -$33 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | -$0 | -$0 |
| Net Acquisitions | $0 | -$2 | -$0 | $0 |
| Inv. Purchases | -$6 | -$6 | -$4 | -$14 |
| Inv. Sales/Matur. | $6 | $9 | $21 | $25 |
| Other Inv. Act. | -$0 | $0 | $0 | -$0 |
| Investing Cash Flow | -$1 | $1 | $18 | $11 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $9 | $6 | $0 | $17 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $9 | $6 | $0 | $17 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $2 | $1 | -$1 | -$4 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $3 | $2 | $3 | $7 |
| End Cash | $5 | $3 | $2 | $3 |
| Free Cash Flow | -$6 | -$6 | -$19 | -$33 |